SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.

SARS-CoV-2 is a betacoronavirus and the etiological agent of COVID-19, a devastating infectious disease. Due to its far-reaching effect on human health, there is an urgent and growing need to understand the viral molecular biology of SARS-CoV-2 and its interaction with the host cell. SARS-CoV-2 enco...

Full description

Saved in:
Bibliographic Details
Main Authors: Ross Hall, Anabel Guedán, Melvyn W Yap, George R Young, Ruth Harvey, Jonathan P Stoye, Kate N Bishop
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-08-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010349&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849337138618826752
author Ross Hall
Anabel Guedán
Melvyn W Yap
George R Young
Ruth Harvey
Jonathan P Stoye
Kate N Bishop
author_facet Ross Hall
Anabel Guedán
Melvyn W Yap
George R Young
Ruth Harvey
Jonathan P Stoye
Kate N Bishop
author_sort Ross Hall
collection DOAJ
description SARS-CoV-2 is a betacoronavirus and the etiological agent of COVID-19, a devastating infectious disease. Due to its far-reaching effect on human health, there is an urgent and growing need to understand the viral molecular biology of SARS-CoV-2 and its interaction with the host cell. SARS-CoV-2 encodes 9 predicted accessory proteins, which are presumed to be dispensable for in vitro replication, most likely having a role in modulating the host cell environment to aid viral replication. Here we show that the ORF6 accessory protein interacts with cellular Rae1 to inhibit cellular protein production by blocking mRNA export. We utilised cell fractionation coupled with mRNAseq to explore which cellular mRNA species are affected by ORF6 expression and show that ORF6 can inhibit the export of many mRNA including those encoding antiviral factors such as IRF1 and RIG-I. We also show that export of these mRNA is blocked in the context of SARS-CoV-2 infection. Together, our studies identify a novel mechanism by which SARS-CoV-2 can manipulate the host cell environment to supress antiviral responses, providing further understanding to the replication strategies of a virus that has caused an unprecedented global health crisis.
format Article
id doaj-art-b5485d2c26534f929a413fdf09b36359
institution Kabale University
issn 1553-7366
1553-7374
language English
publishDate 2022-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-b5485d2c26534f929a413fdf09b363592025-08-20T03:44:46ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742022-08-01188e101034910.1371/journal.ppat.1010349SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.Ross HallAnabel GuedánMelvyn W YapGeorge R YoungRuth HarveyJonathan P StoyeKate N BishopSARS-CoV-2 is a betacoronavirus and the etiological agent of COVID-19, a devastating infectious disease. Due to its far-reaching effect on human health, there is an urgent and growing need to understand the viral molecular biology of SARS-CoV-2 and its interaction with the host cell. SARS-CoV-2 encodes 9 predicted accessory proteins, which are presumed to be dispensable for in vitro replication, most likely having a role in modulating the host cell environment to aid viral replication. Here we show that the ORF6 accessory protein interacts with cellular Rae1 to inhibit cellular protein production by blocking mRNA export. We utilised cell fractionation coupled with mRNAseq to explore which cellular mRNA species are affected by ORF6 expression and show that ORF6 can inhibit the export of many mRNA including those encoding antiviral factors such as IRF1 and RIG-I. We also show that export of these mRNA is blocked in the context of SARS-CoV-2 infection. Together, our studies identify a novel mechanism by which SARS-CoV-2 can manipulate the host cell environment to supress antiviral responses, providing further understanding to the replication strategies of a virus that has caused an unprecedented global health crisis.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010349&type=printable
spellingShingle Ross Hall
Anabel Guedán
Melvyn W Yap
George R Young
Ruth Harvey
Jonathan P Stoye
Kate N Bishop
SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
PLoS Pathogens
title SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
title_full SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
title_fullStr SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
title_full_unstemmed SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
title_short SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export.
title_sort sars cov 2 orf6 disrupts innate immune signalling by inhibiting cellular mrna export
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1010349&type=printable
work_keys_str_mv AT rosshall sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport
AT anabelguedan sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport
AT melvynwyap sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport
AT georgeryoung sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport
AT ruthharvey sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport
AT jonathanpstoye sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport
AT katenbishop sarscov2orf6disruptsinnateimmunesignallingbyinhibitingcellularmrnaexport